Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring
- PMID: 20737211
- DOI: 10.1007/s10620-010-1381-4
Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring
Abstract
Background: Patients with typical reflux symptoms (heartburn/regurgitation) persisting despite proton pump inhibitor (PPI) therapy are not uncommon. Impedance-pH monitoring detects gastroesophageal reflux at all pH levels and may establish if ongoing symptoms on PPI therapy are associated with acid/nonacid reflux. Laparoscopic fundoplication is a therapeutic option in such patients but reflux parameters on PPI therapy and after intervention and their relationship with symptom persistence/remission have been scarcely studied.
Aims: The aim of this study was to assess reflux parameters and their relationship with symptoms before and after laparoscopic fundoplication, on and off PPI therapy, respectively, in patients with PPI-unresponsive heartburn/regurgitation and with a positive symptom-reflux association and/or abnormal reflux parameters detected on PPI therapy.
Methods: Impedance-pH monitoring was performed on high-dose PPI therapy and 3 months after laparoscopic fundoplication, off PPI therapy, in 40 patients with PPI-unresponsive heartburn/regurgitation. Symptoms were scored by a validated questionnaire.
Results: Esophageal acid exposure time as well as the number of total and proximal reflux events and of acid and weakly acidic refluxes decreased significantly after surgery: normal values were found in 100, 77, 95, 92 and 65% of cases, respectively. Weakly alkaline refluxes increased significantly postoperatively but neither before nor after intervention were associated with symptoms. All patients reported total/subtotal remission of heartburn/regurgitation 3 months after surgery.
Conclusions: Laparoscopic fundoplication improves acid and weakly acidic reflux parameters when compared with PPI therapy. This improvement justifies the very high post-surgical symptom remission rate that we observed. Prolonged follow-up is warranted but our findings strongly support the surgical option in PPI failures.
Similar articles
-
Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.Surg Endosc. 2013 Aug;27(8):2940-6. doi: 10.1007/s00464-013-2861-3. Epub 2013 Feb 23. Surg Endosc. 2013. PMID: 23436097
-
Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD.Aliment Pharmacol Ther. 2011 Jul;34(1):67-75. doi: 10.1111/j.1365-2036.2011.04677.x. Epub 2011 May 3. Aliment Pharmacol Ther. 2011. PMID: 21539587
-
24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.Neurogastroenterol Motil. 2016 Jan;28(1):146-52. doi: 10.1111/nmo.12715. Epub 2015 Nov 3. Neurogastroenterol Motil. 2016. PMID: 26526815
-
Laparoscopic fundoplication for gastroesophageal reflux disease.World J Gastroenterol. 2014 Oct 21;20(39):14272-9. doi: 10.3748/wjg.v20.i39.14272. World J Gastroenterol. 2014. PMID: 25339814 Free PMC article. Review.
-
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.Clin Gastroenterol Hepatol. 2022 May;20(5):984-994.e1. doi: 10.1016/j.cgh.2022.01.025. Epub 2022 Feb 2. Clin Gastroenterol Hepatol. 2022. PMID: 35123084 Free PMC article. Review.
Cited by
-
New Approaches to Management of PPI-Refractory Gastroesophageal Reflux Disease.Curr Treat Options Gastroenterol. 2014 Mar;12(1):18-33. doi: 10.1007/s11938-013-0002-7. Curr Treat Options Gastroenterol. 2014. PMID: 24430334
-
Role of non-acid reflux in patients with non-erosive reflux disease.Ann Gastroenterol. 2013;26(2):100-103. Ann Gastroenterol. 2013. PMID: 24714866 Free PMC article. Review.
-
NERD: an umbrella term including heterogeneous subpopulations.Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):371-80. doi: 10.1038/nrgastro.2013.50. Epub 2013 Mar 26. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23528345 Review.
-
Recent insights on functional heartburn and reflux hypersensitivity.Curr Opin Gastroenterol. 2022 Jul 1;38(4):417-422. doi: 10.1097/MOG.0000000000000846. Curr Opin Gastroenterol. 2022. PMID: 35762702 Free PMC article. Review.
-
Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art.Drug Des Devel Ther. 2021 Apr 19;15:1609-1621. doi: 10.2147/DDDT.S306371. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33907381 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical